News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jain PharmaBiotech Publications Announces The Release Of A New Report Titled "Gene therapy - Technologies, Markets And Companies"



10/19/2005 5:10:42 PM

BASEL, Switzerland, April 5 /PRNewswire/ -- This report takes a broad overview of gene therapy technologies and is the most up-to-date presentation from the author on this topic built-up from his experience and a series of gene therapy report written by him during the past decade, a textbook of gene therapy and a book on gene therapy companies. This report describes the setbacks of gene therapy and renewed interest in the topic. Gene therapy technologies and clinical applications are described in detail. The report also discusses the adverse effects of various vectors, safety regulations and ethical aspects of gene therapy. Profiles of 176 companies are presented as an update from the John Wiley & Sons Gene Medicine Web site maintained by the author from 2001-2003. Gene therapy markets are estimated for the years 2005- 2015 based on epidemiology of diseases to be treated with gene therapy, the portion of patients who will be eligible for these treatments, competing technologies and the technical developments anticipated in the next decade.

For further information about this report visit: http://www.pharmabiotech.ch/reports/genetherapy/

Jain PharmaBiotech is a biotechnology consulting company that has produced over 42 strategic reports during the past 9 years. Other publishers have marketed some of these but gene therapy report is one of the 13 that are constantly updated and published in house. Other reports are:

Alzheimer's disease: New Drugs, Markets, and Companies. http://pharmabiotech.ch/reports/ad/

Animal Biotechnology: Technologies, Markets and Companies. http://pharmabiotech.ch/reports/animalbiotech/

Cell therapy: Technologies, Markets and Companies. http://pharmabiotech.ch/reports/celltherapy/

Drug Delivery in Cancer - technologies, markets and companies. http://www.pharmabiotech.ch/reports/cancer/

Molecular diagnostics: Technologies, Markets and Companies. http://pharmabiotech.ch/reports/mdx/

Neuroprotection: Drugs, Markets and Companies. http://pharmabiotech.ch/reports/np/

Nitric Oxide: Therapeutics, Markets and Companies. http://pharmabiotech.ch/reports/nitox/

Pain Therapeutics: Drugs, Markets and Companies. http://pharmabiotech.ch/reports/pain/

Personalized Medicine: Scientific & Commercial Aspects. http://pharmabiotech.ch/reports/persmed/

Proteomics: Technologies, Markets and Companies. http://pharmabiotech.ch/reports/proteomics/

RNAi - technologies, markets and companies. http://www.pharmabiotech.ch/reports/rnai/

Transdermal Drug Delivery: Technologies, Markets, and Companies. http://pharmabiotech.ch/reports/tdd/

Prof. Dr. med. K. K. Jain Jain PharmaBiotech Blaesiring 7 4057 Basel, Switzerland Tel & Fax: +4161 692 4461 Mobile: +41(0) 79-685 6337 E-mail: jain@pharmabiotech.chhttp://pharmabiotech.ch/

Jain PharmaBiotech

CONTACT: Prof. Dr. med. K. K. Jain of Jain PharmaBiotech, Tel & Fax,+4161-692-4461, or Mobile, +41-79-685 6337


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES